Products

Compare Products

Side-by-side comparison of veterinary products

1 Products
Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8
Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8
Biological

Zoetis

Canine Influenza Virus (H3N2 & H3N8, Inactivated)

Search to add a product

Search to add a product

Attribute Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8
Image Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8
Trade Name Vanguard CIV Canine Influenza Vaccine H3N2 and H3N8

فانغارد سي آي في لقاح إنفلونزا الكلاب الثنائي المعطل
Product Type Biological
Dosage Form —
Manufacturer Zoetis
Active Ingredients
Diseases —
Package Size Pack of 25 x 1 mL single-dose vials
Storage Conditions Store in the dark between 2° and 8°C (35° and 46°F). Do not freeze. Shake well before use.
Dosages

Dog

  • 1 mL administered subcutaneously in healthy dogs 8 weeks of age or older. Primary series requires 2 doses 3 weeks apart. (Subcutaneous (SC)) — Primary 2-dose series 3 weeks apart; revaccinate annually
Withdrawal Periods

Dog
Indications
  • Vaccination of healthy dogs 8 weeks of age or older as an aid in the control of disease associated with Canine Influenza Virus subtypes H3N2 and H3N8.
Contraindications
  • Do not vaccinate sick, feverish, or severely debilitated dogs.
Precautions
  • Contains thimerosal, gentamicin, and amphotericin B as preservatives. Epinephrine should be administered if anaphylaxis occurs.
Side Effects
  • Transient localized injection site swelling, mild lethargy, or low-grade fever resolving within 24 hours.

This website uses cookies to ensure you get the best experience.